Uni-Bio Science Group Ltd (UNBSF)
0.004
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Uni-Bio Science Group Price to Book Value: 0.6012 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 0.6012 |
| November 13, 2024 | 0.6012 |
| November 12, 2024 | 0.6012 |
| November 11, 2024 | 0.6012 |
| November 08, 2024 | 0.6012 |
| November 07, 2024 | 0.6012 |
| November 06, 2024 | 0.6012 |
| November 05, 2024 | 0.6012 |
| Date | Value |
|---|---|
| November 04, 2024 | 0.6012 |
| November 01, 2024 | 0.6012 |
| October 31, 2024 | 0.6012 |
| October 30, 2024 | 0.6012 |
| October 29, 2024 | 0.6012 |
| October 28, 2024 | 0.6012 |
| October 25, 2024 | 0.6012 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6012
Minimum
Oct 25 2024
0.6012
Maximum
Oct 25 2024
0.6012
Average
0.6012
Median
Oct 25 2024
Price to Book Value Benchmarks
| Sino Biopharmaceutical Ltd | 1.732 |
| HUTCHMED (China) Ltd | 3.868 |
| Pharmaron Beijing Co Ltd | -- |
| Regencell Bioscience Holdings Ltd | 9.975 |
| Prenetics Global Ltd | 0.3122 |
Price to Book Value Related Metrics
| PE Ratio | 1.979 |
| PS Ratio | 0.3852 |
| Price to Free Cash Flow | 1.598 |
| Price | 0.004 |
| Earnings Yield | 50.52% |
| Market Cap | 24.07M |
| Operating PE Ratio | 1.965 |
| Normalized PE Ratio | 1.979 |